388 related articles for article (PubMed ID: 21220701)
1. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: just a biomarker of inflammation or a pathophysiological player in myocardial function and morphology?
Schulz R; Heusch G
Hypertension; 2011 Feb; 57(2):151-3. PubMed ID: 21220709
[No Abstract] [Full Text] [Related]
4. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
7. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
[TBL] [Abstract][Full Text] [Related]
8. Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments.
Patel VB; Wang Z; Fan D; Zhabyeyev P; Basu R; Das SK; Wang W; Desaulniers J; Holland SM; Kassiri Z; Oudit GY
Circ Res; 2013 Jun; 112(12):1542-56. PubMed ID: 23553616
[TBL] [Abstract][Full Text] [Related]
9. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
Zhong B; Rubinstein J; Ma S; Wang DH
Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
11. Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.
Suzuki S; Shishido T; Funayama A; Netsu S; Ishino M; Kitahara T; Sasaki T; Katoh S; Otaki Y; Watanabe T; Shibata Y; Mantovani A; Takeishi Y; Kubota I
PLoS One; 2013; 8(1):e53133. PubMed ID: 23372656
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
14. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway.
Kong JC; Miao WQ; Wang Y; Zhou SF
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
16. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
[TBL] [Abstract][Full Text] [Related]
17. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
18. Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits.
Li B; Tian J; Sun Y; Xu TR; Chi RF; Zhang XL; Hu XL; Zhang YA; Qin FZ; Zhang WF
Biochim Biophys Acta; 2015 May; 1852(5):805-15. PubMed ID: 25615792
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
